MP70-15 INTRA-PROSTATIC PRX302 FOCAL THERAPY IN TREATING CLINICALLY SIGNIFICANT LOW-INTERMEDIATE PROSTATE CANCER: AN OPEN LABEL, PROOF-OF-CONCEPT STUDY

Citation:
Edward Bass, Y. Shanmugabavan, Shanmugabavan, and Mohamed Eltemamy, "MP70-15 INTRA-PROSTATIC PRX302 FOCAL THERAPY IN TREATING CLINICALLY SIGNIFICANT LOW-INTERMEDIATE PROSTATE CANCER: AN OPEN LABEL, PROOF-OF-CONCEPT STUDY", Journal of Urology, vol. 197, issue 4, pp. 940-941, 2017.
Tourism